These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

631 related articles for article (PubMed ID: 23475416)

  • 1. Leptin's role in lipodystrophic and nonlipodystrophic insulin-resistant and diabetic individuals.
    Moon HS; Dalamaga M; Kim SY; Polyzos SA; Hamnvik OP; Magkos F; Paruthi J; Mantzoros CS
    Endocr Rev; 2013 Jun; 34(3):377-412. PubMed ID: 23475416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leptin in relation to the lipodystrophy-associated metabolic syndrome.
    Mantzoros CS
    Diabetes Metab J; 2012 Jun; 36(3):181-9. PubMed ID: 22737657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leptin in congenital and HIV-associated lipodystrophy.
    Tsoukas MA; Farr OM; Mantzoros CS
    Metabolism; 2015 Jan; 64(1):47-59. PubMed ID: 25267014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapy resistant diabetes mellitus and lipodystrophy: leptin therapy leads to improvement].
    Jazet IM; Jonker JT; Wijngaarden MA; Lamb H; Smelt AH
    Ned Tijdschr Geneeskd; 2013; 157(4):A5482. PubMed ID: 23343738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adipokines in the HIV/HAART-associated lipodystrophy syndrome.
    Paruthi J; Gill N; Mantzoros CS
    Metabolism; 2013 Sep; 62(9):1199-205. PubMed ID: 23706880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant methionyl human leptin therapy in replacement doses improves insulin resistance and metabolic profile in patients with lipoatrophy and metabolic syndrome induced by the highly active antiretroviral therapy.
    Lee JH; Chan JL; Sourlas E; Raptopoulos V; Mantzoros CS
    J Clin Endocrinol Metab; 2006 Jul; 91(7):2605-11. PubMed ID: 16636130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leptin action in the ventromedial hypothalamic nucleus is sufficient, but not necessary, to normalize diabetic hyperglycemia.
    Meek TH; Matsen ME; Dorfman MD; Guyenet SJ; Damian V; Nguyen HT; Taborsky GJ; Morton GJ
    Endocrinology; 2013 Sep; 154(9):3067-76. PubMed ID: 23782941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adipocyte-derived hormone levels in HIV lipodystrophy.
    Kosmiski L; Kuritzkes D; Lichtenstein K; Eckel R
    Antivir Ther; 2003 Feb; 8(1):9-15. PubMed ID: 12713059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetes, insulin resistance and dyslipidaemia in lipodystrophic HIV-infected patients on highly active antiretroviral therapy (HAART).
    Vigouroux C; Gharakhanian S; Salhi Y; Nguyen TH; Chevenne D; Capeau J; Rozenbaum W
    Diabetes Metab; 1999 Sep; 25(3):225-32. PubMed ID: 10499191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum adipocytokines are related to lipodystrophy and metabolic disorders in HIV-infected men under antiretroviral therapy.
    Vigouroux C; Maachi M; Nguyên TH; Coussieu C; Gharakhanian S; Funahashi T; Matsuzawa Y; Shimomura I; Rozenbaum W; Capeau J; Bastard JP
    AIDS; 2003 Jul; 17(10):1503-11. PubMed ID: 12824788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leptin ameliorates insulin resistance and hepatic steatosis in Agpat2-/- lipodystrophic mice independent of hepatocyte leptin receptors.
    Cortés VA; Cautivo KM; Rong S; Garg A; Horton JD; Agarwal AK
    J Lipid Res; 2014 Feb; 55(2):276-88. PubMed ID: 24293639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leptin replacement therapy does not improve the abnormal lipid kinetics of hypoleptinemic patients with HIV-associated lipodystrophy syndrome.
    Sekhar RV; Jahoor F; Iyer D; Guthikonda A; Paranilam J; Elhaj F; Coraza I; Balasubramanyam A
    Metabolism; 2012 Oct; 61(10):1395-403. PubMed ID: 22542724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leptin replacement improves postprandial glycemia and insulin sensitivity in human immunodeficiency virus-infected lipoatrophic men treated with pioglitazone: a pilot study.
    Magkos F; Brennan A; Sweeney L; Kang ES; Doweiko J; Karchmer AW; Mantzoros CS
    Metabolism; 2011 Jul; 60(7):1045-9. PubMed ID: 21081243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of generalized lipodystrophy-associated progeroid syndrome treated by leptin replacement with short and long-term monitoring of the metabolic and endocrine profiles.
    Fukaishi T; Minami I; Masuda S; Miyachi Y; Tsujimoto K; Izumiyama H; Hashimoto K; Yoshida M; Takahashi S; Kashimada K; Morio T; Kosaki K; Maezawa Y; Yokote K; Yoshimoto T; Yamada T
    Endocr J; 2020 Feb; 67(2):211-218. PubMed ID: 31708526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of ghrelin and leptin in the regulation of carbohydrate metabolism. Part II. Leptin.
    Otto-Buczkowska E; Chobot A
    Postepy Hig Med Dosw (Online); 2012 Oct; 66():799-803. PubMed ID: 23175334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-cell dysfunction and low insulin clearance in insulin-resistant human immunodeficiency virus (HIV)-infected patients with lipodystrophy.
    Haugaard SB; Andersen O; Vølund A; Hansen BR; Iversen J; Andersen UB; Nielsen JO; Madsbad S
    Clin Endocrinol (Oxf); 2005 Mar; 62(3):354-61. PubMed ID: 15730419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced Endothelial Leptin Signaling Increases Vascular Adrenergic Reactivity in a Mouse Model of Congenital Generalized Lipodystrophy.
    Bruder-Nascimento T; Kress TC; Pearson M; Chen W; Kennard S; Belin de Chantemèle EJ
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One-year metreleptin improves insulin secretion in patients with diabetes linked to genetic lipodystrophic syndromes.
    Vatier C; Fetita S; Boudou P; Tchankou C; Deville L; Riveline J; Young J; Mathivon L; Travert F; Morin D; Cahen J; Lascols O; Andreelli F; Reznik Y; Mongeois E; Madelaine I; Vantyghem M; Gautier J; Vigouroux C
    Diabetes Obes Metab; 2016 Jul; 18(7):693-7. PubMed ID: 26584826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical, randomized phase 1, and compassionate use evaluation of REGN4461, a leptin receptor agonist antibody for leptin deficiency.
    Altarejos JY; Pangilinan J; Podgrabinska S; Akinci B; Foss-Freitas M; Neidert AH; Ray Y; Zheng W; Kim S; Kamat V; Huang M; Min S; Mastaitis J; Dominguez-Gutierrez G; Kim JH; Stevis P; Huang T; Zambrowicz B; Olson WC; Godin S; Bradley E; Gewitz AD; Baker M; Hench R; Davenport MS; Chenevert TL; DiPaola F; Yancopoulos GD; Murphy AJ; Herman GA; Musser BJ; Dansky H; Harp J; Gromada J; Sleeman MW; Oral EA; Olenchock BA
    Sci Transl Med; 2023 Nov; 15(723):eadd4897. PubMed ID: 37992152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metreleptin for injection to treat the complications of leptin deficiency in patients with congenital or acquired generalized lipodystrophy.
    Meehan CA; Cochran E; Kassai A; Brown RJ; Gorden P
    Expert Rev Clin Pharmacol; 2016; 9(1):59-68. PubMed ID: 26465174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.